AcelRx Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Talphera

16/08/2021 22:17

* AcelRx Pharmaceuticals Inc  ACRX.OQ  reported a quarterly
adjusted loss of 8 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 8 cents per share.
* Revenue fell 84.8% to $443.00 thousand from a year ago; 
analysts expected $1.81 million. 
* AcelRx Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 8 cents​.
* The mean earnings estimate of analysts had risen by about 4.2%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* AcelRx Pharmaceuticals Inc shares had fallen by 15.2% this
quarter and lost 5.6% so far this year.
* The company reported a quarterly loss of $9.85 million.
* Wall Street's median 12-month price target for AcelRx
Pharmaceuticals Inc is $7.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 09:17 p.m.  ​All
figures in US dollars unless otherwise stated